Allergy Therapeutics Plc - Company Profile
Powered by 
All the sales intelligence you need on Allergy Therapeutics Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Allergy Therapeutics Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Allergy Therapeutics Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Allergy Therapeutics Plc (Allergy Therapeutics) is a speciality pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers aluminium-free allergy vaccines and diagnostics. Allergy Therapeutics product portfolio includes Grass Modified Allergen Tyrosine Adsorbed (MATA), Tree MATA, Ragweed MATA, Bee Venom Subcutaneous Immunotherapy (SCIT), and Wasp venom SCIT, among others. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise Pollen, Moulds, Arthropods, Epithelia and others. It has an operational presence in Germany, Italy, Spain, Austria, Switzerland, the Netherlands and the UK, among others. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.
Headquarters
United Kingdom
Address
Dominion Way, Worthing, England, BN148SA
Website
www.allergytherapeutics.com
Telephone
44 1903 844700
No of Employees
584
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
AGY (LON)
Revenue (2025)
$70.3M
-0.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-3.9%
(2025 vs 2024)
Market Cap*
$529.5M
Net Profit Margin (2025)
XYZ
-4.2%
(2025 vs 2024)
* As of and is in US$
Allergy Therapeutics Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Vaccines: | Pollinex |
| Pollen-related Allergies | Oralvac |
| Allergies to Weeds and Trees | Tyrosine |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Allergy Therapeutics Plc | Roxall Medizin GmbH | Allergopharma GmbH & Co KG | Biomay AG | HAL Allergy BV |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | Germany | Germany | Austria | Netherlands |
| City | Worthing | Oststeinbek | Reinbek | Vienna | Leiden |
| State/Province | England | Hamburg | Schleswig-Holstein | Wien | Zuid-Holland |
| No. of Employees | 584 | 48 | - | - | - |
| Entity Type | Public | Private | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Manuel Llobet | Chief Executive Officer; Director | Executive Board | 2009 | - |
| Shaun Furlong | Director; Chief Financial Officer | Executive Board | 2024 | - |
| Helge Weiner-Trapness | Chief Strategy Officer; Director | Executive Board | 2026 | - |
| Peter Jensen | Chairman | Non Executive Board | 2011 | - |
| Karley Cheesman | Company Secretary | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer